Arrowhead Pharmaceuticals (ARWR)
(Delayed Data from NSDQ)
$22.12 USD
+0.25 (1.14%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $22.12 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Earnings Date | *AMC5/9/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | -1.24 |
Last EPS Surprise | -58.97% |
ABR | 1.69 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.70 |
Next Year | -2.53 |
EPS (TTM) | -2.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 82.28M | 40.34M | 135.28M | 272.42M |
# of Estimates | 6 | 5 | 8 | 6 |
High Estimate | 250.00M | 75.50M | 302.00M | 516.20M |
Low Estimate | 24.20M | 10.00M | 3.55M | 158.32M |
Year ago Sales | 146.27M | 15.83M | 240.74M | 135.28M |
Year over Year Growth Est. | -43.75% | 154.83% | -43.80% | 101.37% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | -0.64 | -2.70 | -2.53 |
# of Estimates | 9 | 7 | 11 | 10 |
Most Recent Consensus | -0.47 | -0.48 | -3.02 | -2.64 |
High Estimate | 3.27 | -0.24 | -1.26 | 0.20 |
Low Estimate | -0.95 | -0.95 | -4.07 | -3.98 |
Year ago EPS | 0.45 | -0.96 | -1.92 | -2.70 |
Year over Year Growth Est. | -113.33% | 33.33% | -40.63% | 6.09% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.06 | -0.64 | -2.70 | -2.53 |
7 Days Ago | -0.06 | -0.64 | -2.70 | -2.53 |
30 Days Ago | -0.06 | -0.64 | -2.70 | -2.53 |
60 Days Ago | -0.06 | -0.64 | -2.70 | -2.53 |
90 Days Ago | -0.04 | -0.83 | -3.27 | -2.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.06 | -0.64 | -2.70 | -2.53 |
Zacks Consensus Estimate | -0.06 | -0.64 | -2.70 | -2.53 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.24 | -1.03 | -0.96 | 0.45 | NA |
Estimate | -0.78 | -0.70 | -0.58 | -0.65 | NA |
Difference | -0.46 | -0.33 | -0.38 | 1.10 | -0.02 |
Surprise | -58.97% | -47.14% | -65.52% | 169.23% | -0.60% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more